Cisplatin Nephrotoxicity and Protection by Milk Thistle Extract in Rats

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2005 Sep 2

PMID 16136217

Citations 30

Authors

Gholamreza Karimi

Mohammad Ramezani

Zahra Tahoonian

Affiliations

Soon will be listed here.

Abstract

The protective effect of methanolic extract of milk thistle seeds and silymarin against cisplatin-induced renal toxicity in male rats after a single intraperitoneal injection of 3 mg kg cisplatin were studied. Over 5 days, cisplatin-treated rats showed tubular necrosis and elevation in blood urea nitrogen (BUN) and serum creatinine (Scr). Pretreatment of animals with silymarin (50 mg kg) or extract (0.6 g kg) 2 h before cisplatin prevented the tubular damage. Rats treated with silymarin or extract 2 h after cisplatin had BUN and Scr significantly lower than those receiving cisplatin, but mild to moderate necrosis was observed. These results suggested that milk thistle may protect against cisplatin-induced renal toxicity and might serve as a novel combination agent with cisplatin to limit renal injury.

Citing Articles

Nephroprotective and Antioxidant Effects of Extract Against Ischemia-Reperfusion Injury in Wistar Rats.

Rodriguez-Rodriguez D, Mendoza-Hernandez O, Cordero-Perez P, Rivas-Galindo V, Moreno-Pena D, Tijerina-Marquez R Int J Mol Sci. 2025; 26(5).

PMID: 40076464 PMC: 11899379. DOI: 10.3390/ijms26051838.

Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches.

da Cunha Lyrio R, Rocha B, Correa A, Mascarenhas M, Santos F, Maia R Front Nephrol. 2024; 4:1436896.

PMID: 39185276 PMC: 11341478. DOI: 10.3389/fneph.2024.1436896.

Protective effects of lupeol in rats with renal ischemia‑reperfusion injury.

Kapisiz A, Kaya C, Eryilmaz S, Karabulut R, Turkyilmaz Z, Inan M Exp Ther Med. 2024; 28(2):313.

PMID: 38911048 PMC: 11190881. DOI: 10.3892/etm.2024.12602.

Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

Malik A, Malik M, Qureshi S Can Liver J. 2024; 7(1):40-53.

PMID: 38505782 PMC: 10946183. DOI: 10.3138/canlivj-2023-0021.

Natural feed additives and bioactive supplements versus chemical additives as a safe and practical approach to combat foodborne mycotoxicoses.

Stoev S Front Nutr. 2024; 11:1335779.

PMID: 38450227 PMC: 10915786. DOI: 10.3389/fnut.2024.1335779.

References

Rubanyi G, Vanhoutte P . Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250(5 Pt 2):H822-7. DOI: 10.1152/ajpheart.1986.250.5.H822. View

Havsteen B . Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983; 32(7):1141-8. DOI: 10.1016/0006-2952(83)90262-9. View

Winston J, Safirstein R . Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985; 249(4 Pt 2):F490-6. DOI: 10.1152/ajprenal.1985.249.4.F490. View

Montine T, Borch R . Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplatinum(II)-induced nephrotoxicity. Biochem Pharmacol. 1990; 39(11):1751-7. DOI: 10.1016/0006-2952(90)90121-z. View

Modlinger P, Wilcox C, Aslam S . Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol. 2004; 24(4):354-65. DOI: 10.1016/j.semnephrol.2004.04.007. View

Rao M, Rao M . Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats. J Pharm Pharmacol. 1998; 50(6):687-91. DOI: 10.1111/j.2042-7158.1998.tb06906.x. View

Xiao T, Choudhary S, Zhang W, Ansari N, Salahudeen A . Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A. 2003; 66(5):469-79. DOI: 10.1080/15287390306449. View

Zhao B . Natural antioxidants for neurodegenerative diseases. Mol Neurobiol. 2005; 31(1-3):283-93. DOI: 10.1385/MN:31:1-3:283. View

Mora A, Paya M, Rios J, Alcaraz M . Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol. 1990; 40(4):793-7. DOI: 10.1016/0006-2952(90)90317-e. View

10.

Chirino Y, Hernandez-Pando R, Pedraza-Chaverri J . Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol. 2004; 4:20. PMC: 526185. DOI: 10.1186/1471-2210-4-20. View

11.

Mora L, Antunes L, Francescato H, Bianchi M . The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2003; 47(6):517-22. DOI: 10.1016/s1043-6618(03)00040-9. View

12.

Gaedeke J, Fels L, Bokemeyer C, Mengs U, STOLTE H, Lentzen H . Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant. 1996; 11(1):55-62. View

13.

Heidemann H, Gerkens J, Jackson E, Branch R . Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(2):201-5. DOI: 10.1007/BF00501213. View

14.

Jones T, Chopra S, Kaufman J, Flamenbaum W, Trump B . Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. Lab Invest. 1985; 52(4):363-74. View

15.

Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M . Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol. 1987; 43(3):247-52. DOI: 10.1254/jjp.43.247. View

16.

Rozencweig M, Von Hoff D, Slavik M, Muggia F . Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann Intern Med. 1977; 86(6):803-12. DOI: 10.7326/0003-4819-86-6-803. View

17.

Antunes L, Darin J, Bianchi M . Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res. 2000; 41(4):405-11. DOI: 10.1006/phrs.1999.0600. View

18.

Singh D, Chander V, Chopra K . Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmacol Rep. 2005; 57(1):70-6. View

19.

Baliga R, Zhang Z, Baliga M, Ueda N, Shah S . In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998; 53(2):394-401. DOI: 10.1046/j.1523-1755.1998.00767.x. View